Lessons from TGN1412
The DOI matches its Crossref record; 3 of the 4 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Toward this end, cynomolgus and rhesus monkeys were chosen because the CD28 receptor in these species and humans have similar affinity for TGN1412[5] because of 100% sequence homology of extracellular domain of CD28 receptor.[5]”
From TGN1412: From Discovery to Disaster (2010) · cites this paper as [5]
In the citing paper
“the entire external domain of cynomolgus macaque CD28 (and, indeed, also of the rhesus molecule; the published sequence on which the claim of poor binding was based is wrong) is identical to that of human CD28”
From The rise and fall of the CD 28 superagonist TGN 1412 and its return as TAB 08: a personal account (2016) · cites this paper as [39]
In the citing paper
“affinities of TGN1412 binding to macaque and human CD28 [measured by surface plasmon resonance (Biacore) and flow cytometry] are indistinguishable [39].”
From The rise and fall of the CD 28 superagonist TGN 1412 and its return as TAB 08: a personal account (2016) · cites this paper as [39]
Citations
Cites
Establishing risk of human experimentation with drugs: lessons from TGN1412
Kenter, M., & Cohen, A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69562-7 · Cited by 153
Legrand, N., Cupedo, T., van Lent, A. U., Ebeli, M. J., Weijer, K., Hanke, T., & Spits, H. (2006) · Blood · doi:10.1182/blood-2006-01-0190 · Cited by 82
Self-citationCTLA-4 Blockade: Autoimmunity As Treatment
Kapadia, D., & Fong, L. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.012 · Cited by 36
Cited by
The safety and side effects of monoclonal antibodies
Hansel, T. T., Kropshofer, H., Singer, T., Mitchell, J. A., & George, A. J. T. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3003 · Cited by 1,144
The perfect mix: recent progress in adjuvant research
Guy, B. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1681 · Cited by 620
Stebbings, R., Findlay, L., Edwards, C., Eastwood, D., Bird, C., North, D., Mistry, Y., Dilger, P., Liefooghe, E., Cludts, I., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.3325 · Cited by 316
TGN1412: From Discovery to Disaster
Attarwala, H. (2010) · Journal of Young Pharmacists · doi:10.4103/0975-1483.66810 · Cited by 253
“Toward this end, cynomolgus and rhesus monkeys were chosen because the CD28 receptor in these species and humans have similar affinity for TGN1412[5] because of 100% sequence homology of extracellular domain of CD28 receptor.[5] Moreover, Fc receptors and their motifs responsible for signal transduction in these speci…”
The storm has cleared: lessons from the CD28 superagonist TGN1412 trial
Hünig, T. (2012) · Nature Reviews Immunology · doi:10.1038/nri3192 · Cited by 194
Metadata
- Authors
- Hanke, T.
- Corresponding author
- Hanke, Thomas
- ORCID
- Hanke, Thomas
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2006-11
- Volume
- 368
- Issue
- 9547
- Pages
- 1569-1570
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2075363200
- Cited by
- 65
- References
- 4
- Citations by year
- 2025: 3 · 2024: 2 · 2023: 3 · 2022: 3 · 2020: 4 · 2019: 4 · 2018: 4 · 2017: 4 · 2016: 3 · 2015: 2 · 2014: 6 · 2013: 1 · 2012: 5
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Keywords
- TGN1412, anti-CD28 monoclonal antibody, antibody affinity, T cell activation, cytokine release syndrome, drug safety assessment, animal model limitations, humanized monoclonal antibody
- MeSH terms
- Animals, Antibodies, Monoclonal, Humans, Interleukins, Leukocytes, Mononuclear, Macaca fascicularis, Species Specificity, Clinical Trials, Phase I as Topic, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lessons from TGN1412. https://app.cochat.ai/papers/10.1016/s0140-6736(06)69651-7
- The paper
- Hanke, T. (2006). Lessons from TGN1412. The Lancet. https://doi.org/10.1016/s0140-6736(06)69651-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.